Methyl 2-[((adamantan-1-yl)carbonyl)amino]-5-ethyl-4-methylthiophene-3-carboxylate

ID: ALA4476681

PubChem CID: 155538552

Max Phase: Preclinical

Molecular Formula: C20H27NO3S

Molecular Weight: 361.51

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCc1sc(NC(=O)C23CC4CC(CC(C4)C2)C3)c(C(=O)OC)c1C

Standard InChI:  InChI=1S/C20H27NO3S/c1-4-15-11(2)16(18(22)24-3)17(25-15)21-19(23)20-8-12-5-13(9-20)7-14(6-12)10-20/h12-14H,4-10H2,1-3H3,(H,21,23)

Standard InChI Key:  LMFJEFWVETVREV-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
    8.8010   -8.5920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1945   -9.2990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0100   -8.8478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4756   -9.0683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2485   -8.5791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7390   -9.2826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0474   -9.6914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5239  -10.3735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2316  -10.0901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7668  -10.0975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5370  -10.4956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3583  -10.4956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6127   -9.7147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9456   -9.2326    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.2869   -9.7147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3200   -9.2986    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8379  -11.1614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5046  -11.9117    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6584  -11.1600    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.0362   -9.6996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0449  -10.5209    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9856  -12.5724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5097   -9.4620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3401   -8.6626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0553  -11.1557    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  2  4  1  0
  3  5  1  0
  4  6  1  0
  5  6  1  0
  7  8  1  0
  3  7  1  0
  2  9  1  0
  6 10  1  0
 10  8  1  0
  8  9  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 11  2  0
 13 16  1  0
 12 17  1  0
 17 18  1  0
 17 19  2  0
 16 20  1  0
 20 21  2  0
 20  6  1  0
 18 22  1  0
 15 23  1  0
 23 24  1  0
 11 25  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4476681

    ---

Associated Targets(Human)

CNR2 Tchem Cannabinoid CB2 receptor (16942 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 361.51Molecular Weight (Monoisotopic): 361.1712AlogP: 4.56#Rotatable Bonds: 4
Polar Surface Area: 55.40Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 10.58CX Basic pKa: CX LogP: 6.02CX LogD: 6.02
Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.80Np Likeness Score: -1.09

References

1. Mugnaini C, Rabbito A, Brizzi A, Palombi N, Petrosino S, Verde R, Di Marzo V, Ligresti A, Corelli F..  (2019)  Synthesis of novel 2-(1-adamantanylcarboxamido)thiophene derivatives. Selective cannabinoid type 2 (CB2) receptor agonists as potential agents for the treatment of skin inflammatory disease.,  161  [PMID:30359820] [10.1016/j.ejmech.2018.09.070]

Source